MACQUARIE GROUP LTD - NEOLEUKIN THERAPEUTICS INC ownership

NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 87 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of NEOLEUKIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$86,000
+1620.0%
11,960
+2208.9%
0.00%
Q2 2021$5,000
-16.7%
5180.0%0.00%
Q1 2021$6,000
-45.5%
518
-32.2%
0.00%
Q4 2020$11,000
+22.2%
7640.0%0.00%
Q3 2020$9,000
-30.8%
7640.0%0.00%
Q2 2020$13,000
-79.4%
764
-86.3%
0.00%
Q1 2020$63,0005,5710.00%
Other shareholders
NEOLEUKIN THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,156,200$10,672,0001.77%
ACT CAPITAL MANAGEMENT, LLC 239,000$2,207,0001.13%
EcoR1 Capital, LLC 2,358,804$21,772,0000.81%
Redmile Group, LLC 3,919,235$36,175,0000.54%
Boxer Capital, LLC 1,501,058$13,855,0000.49%
Baker Brothers Advisors 3,821,740$35,275,0000.16%
Sio Capital Management, LLC 38,312$354,0000.09%
Highland Private Wealth Management 46,999$434,0000.06%
PERSONAL CFO SOLUTIONS, LLC 23,710$219,0000.04%
Point72 Asset Management, L.P. 883,102$8,151,0000.04%
View complete list of NEOLEUKIN THERAPEUTICS INC shareholders